Skip to main content
. 2024 Oct 28;14:25798. doi: 10.1038/s41598-024-76630-4

Table 2.

Characteristics of laboratory variables in patients without post-COVID (group 1) and patients with post-COVID syndrome (group 2) during 6 months follow-up (visit 2).

Variables on follow-up visit (6 months after treatment) Group 1 patients without post-COVID Group 2 patients with post-COVID p-value group 1 vs. group 2 (visit 2)
Leukocytes, µL-1 (median, range) 7.81 (3.35–15.81) 6.05 (4.04–10.73) 0.077
p value (visit 1 vs. visit 2) 0.020 0.300
Platelets, x 1000 µL-1 (median, range) 367 (142–489) 223 (126–412) 0.004
p value (visit 1 vs. visit 2) 0.004 0.124
C-reactive protein, mg/dl (median, range) 1.69 (1.00-93.7) 2.05 (0.86–29.2) 0.649
p value (visit 1 vs. visit 2) 0.009 0.012
Procalcitonin, (median, range) 0.23 (0.02–0.25) 0.05 (0.04–0.05) 0.628
p value (visit 1 vs. visit 2) 0.003 0.654
Ferritin µg/L, (median, range) 367.5 (12-1031) 292.75 (9.6–2556) 0.862
p value (visit 1 vs. visit 2) 0.161 0.441
IL-6 pg/ml, (median, range) 7.95 (1.5–15.8) 2.25 (1.5-634.5) 0.570
p value (visit 1 vs. visit 2) 0.108 0.236

Abbreviations: COVID-19 - Coronavirus disease 19, IL-6 – interleukin 6.